Drug
Azli
Azli: highest development phase Phase 3, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| AZLI NCT03219164 | Phase 3 | Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization |
Latest
No recent events.
Follow Azli on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.